NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 00407-1414-72 — Iohexol 350 contrast injectionAI (274 hospitals, 349,250,224–349,251,979 samples)
• NDC 00407-1414-91 — Iohexol 350 contrast dye injectionAI (708 hospitals, 268,215,170–268,221,173 samples)
• NDC 00407-1414-89 — Omnipaque 350 contrast injectionAI (600 hospitals, 199,313,104–199,318,324 samples)
• NDC 24201-0100-24 — Intravenous acetaminophen 1000 mg/100 mLAI (464 hospitals, 155,913,021–155,913,597 samples)
• NDC 63323-0269-67 — Propofol intravenous emulsion, multiple vial sizesAI (433 hospitals, 138,481,644–138,484,146 samples)
• NDC 67684-2000-03 — Gadoterate meglumine contrast injection for MRIAI (210 hospitals, 101,267,373–101,268,417 samples)
• NDC 00407-1413-61 — Omnipaque 300 contrast injectionAI (701 hospitals, 82,743,268–82,749,496 samples)
• NDC 63323-0117-51 — Fluorouracil 2.5 g/50 mL IV solutionAI (739 hospitals, 74,905,351–74,905,666 samples)
• NDC 00003-3734-13 — Opdivo (nivolumab) 240 mg IV infusion vialAI (884 hospitals, 66,399,348–66,400,680 samples)
• NDC 00407-1414-93 — Omnipaque 350 contrast injectionAI (431 hospitals, 63,600,955–63,602,179 samples)
• NDC 55150-0165-05 — Lidocaine hydrochloride 2% injectionAI (909 hospitals, 57,810,653–57,814,973 samples)
• NDC 00641-6142-25 — Phenylephrine 10 mg/mL injectionAI (617 hospitals, 57,234,009–57,237,582 samples)
• NDC 00338-0117-04 — Lactated Ringer's solution (IV fluid)AI (956 hospitals, 56,972,272–56,988,751 samples)
• NDC 50242-0150-01 — Ocrelizumab 300 mg IV infusionAI (1178 hospitals, 50,418,804–50,419,965 samples)
• NDC 00990-7953-09 — Lactated Ringer's intravenous solutionAI (489 hospitals, 42,236,422–42,241,363 samples)
• NDC 55150-0251-10 — Lidocaine 1% injectable solutionAI (611 hospitals, 40,173,909–40,178,571 samples)
• NDC 00781-3154-01 — Ferumoxytol injection, 510 mg vialAI (627 hospitals, 35,409,000–35,409,936 samples)
• NDC 00338-0117-03 — Lactated Ringer's intravenous solutionAI (632 hospitals, 32,145,515–32,155,991 samples)
• NDC 00338-0117-02 — lactated Ringers intravenous solutionAI (269 hospitals, 26,316,681–26,319,174 samples)
• NDC 63323-0269-29 — Diprivan 200 mg/20 mL IV emulsionAI (1082 hospitals, 26,271,582–26,291,283 samples)
• NDC 00990-7983-09 — Sodium chloride 0.9% IV solutionAI (462 hospitals, 25,416,937–25,425,154 samples)
• NDC 00409-4276-01 — Lidocaine 1% injection solutionAI (851 hospitals, 19,993,700–20,001,089 samples)
• NDC 00338-0049-04 — Sodium chloride 0.9% IV solutionAI (929 hospitals, 19,700,626–19,728,805 samples)
• NDC 00409-4276-02 — Lidocaine 1% injection solutionAI (527 hospitals, 17,137,457–17,140,697 samples)
• NDC 67684-2000-01 — Gadoterate meglumine contrast injection, 10 mL vialAI (267 hospitals, 14,553,177–14,554,113 samples)
• NDC 63323-0269-57 — Propofol 500 mg/50 mL injectable emulsionAI (314 hospitals, 14,249,200–14,250,262 samples)
• NDC 00407-2223-16 — Visipaque 320 contrast injectionAI (484 hospitals, 14,076,837–14,082,660 samples)
• NDC 55150-0162-05 — Lidocaine 1% injection solutionAI (803 hospitals, 11,285,360–11,296,196 samples)
• NDC 00990-7984-23 — Sodium chloride 0.9% IV solutionAI (258 hospitals, 10,630,126–10,630,558 samples)
• NDC 00338-1055-48 — Metronidazole 500 mg IV solutionAI (989 hospitals, 10,121,535–10,124,379 samples)
• NDC 63323-0466-37 — Sensorcaine-MPF 0.5% bupivacaine numbing injectionAI (664 hospitals, 10,053,833–10,060,925 samples)
• NDC 55150-0164-02 — Lidocaine injection, 2% solutionAI (483 hospitals, 10,038,112–10,041,361 samples)
• NDC 63323-0286-35 — Ropivacaine injection solutionAI (785 hospitals, 9,692,294–9,694,337 samples)
• NDC 65250-0266-04 — Exparel (bupivacaine liposome) injectable suspensionAI (310 hospitals, 8,494,506–8,494,884 samples)
• NDC 63323-0482-27 — Lidocaine with epinephrine injectionAI (1033 hospitals, 8,456,808–8,469,093 samples)
• NDC 00407-2223-17 — Visipaque 320 intravenous contrast injectionAI (560 hospitals, 8,233,430–8,238,956 samples)
• NDC 00338-0049-02 — Sodium chloride 0.9% IV solutionAI (872 hospitals, 8,202,427–8,227,168 samples)
• NDC 00003-3774-12 — Opdivo (nivolumab) 100 mg/10 mL IV infusionAI (912 hospitals, 8,128,563–8,129,544 samples)
• NDC 50242-0917-01 — Tecentriq 1200 mg IV infusionAI (1103 hospitals, 7,494,534–7,495,254 samples)
• NDC 00990-7984-36 — Sodium chloride 0.9% saline solution, 50 mL bagAI (194 hospitals, 7,322,585–7,328,237 samples)
• NDC 42023-0159-25 — Epinephrine 1 mg/mL vialAI (1128 hospitals, 6,956,535–6,961,548 samples)
• NDC 00409-1159-02 — Bupivacaine 0.25% injection (preservative-free)AI (740 hospitals, 6,855,307–6,863,011 samples)
• NDC 00990-7983-03 — Sodium chloride 0.9% IV solutionAI (366 hospitals, 5,518,281–5,524,815 samples)
• NDC 00019-0862-50 — Cysto-Conray II urinary bladder contrast solutionAI (345 hospitals, 5,520,865–5,521,828 samples)
• NDC 00264-7750-00 — Lactated Ringer's intravenous solutionAI (521 hospitals, 5,453,328–5,458,980 samples)
• NDC 00338-0049-18 — Intravenous 0.9% saline solutionAI (503 hospitals, 5,423,250–5,441,385 samples)
• NDC 00990-7984-37 — sodium chloride 0.9 % intravenous solutionAI (300 hospitals, 5,379,206–5,382,644 samples)
• NDC 76297-0001-32 — Sodium chloride 0.9% saline bag, 250 mLAI (162 hospitals, 5,291,106–5,295,795 samples)
• NDC 00990-7983-02 — sodium chloride 0.9 % intravenous solutionAI (388 hospitals, 5,255,304–5,261,001 samples)
• NDC 72485-0116-10 — Nicardipine 25 mg/10 mL IV solutionAI (145 hospitals, 5,000,919–5,001,081 samples)